Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

Pilot Grants Available from CGREAL

The Center for Genetic Research Ethics and Law (CGREAL) is currently accepting applications for pilot projects from Case Western Reserve University and Cleveland Clinic faculty who are interested in developing research on:

  • Ethical, legal, and social issues (ELSI) in the design and conduct of human genetic research, or
  • The translation of research results into clinical medicine, public health, and health policy needs related to genetics.
These grants are designed to support exploratory efforts towards the development of larger scholarly projects or lines of research related to CGREAL’s mission to facilitate interdisciplinary inquiry into the ethical, legal, and social implications of new advances in genetic and genomic science.

Criteria for evaluation will focus on the potential for expanding and enriching the range of perspectives being brought to genetic research ethics and law at CGREAL. Preference will be given to projects that are deemed likely to foster further collaborative research opportunities.

Requests may be made for up to $5,000. Funds may not be used for faculty salary support. Applications are encouraged from Case Western University and Cleveland Clinic faculty at any rank/level.

Applications will be accepted on a rolling basis and funding for awarded seed grants will be available immediately upon project approval.

Interested faculty should contact Aaron Goldenberg (aaron.goldenberg@case.edu or 216-368-8729).

For further information on the Center for Genetic Research Ethics and Law, see http://www.case.edu/med/bioethics/cgreal/ .

 
Ohio Third Frontier (OTF), Ohio Development Services Agency

The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:

Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.

Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.

The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.

Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or mhaag@case.edu.

For more information on the TVSF visit the Ohio Third Frontier website.

 
Wellcome Trust (UK)

The Wellcome Trust is a UK-based organization that funds research to improve human and animal health. The Wellcome Trust supports research conducted outside the UK where research develops international partnerships, or focuses on biomedical or clinical medicine in developing countries.

Visit the Wellcome Trust website for more information on available funding.

 
Limited Submission Reminder: NSF Materials Innovation Platforms (MIP)

Key Deadlines: January 5, 2015, 5:00pm (CWRU Internal Submission Deadline), March 2, 2015, 5:00pm EST.

The Division of Materials Research (DMR) seeks to significantly accelerate advances in materials research and engineering through the rapid discovery of new materials and phenomena by developing a new midscale user facility program - Materials Innovation Platforms (MIP) program. MIPs embrace the paradigm set forth by the Materials Genome Initiative (MGI) which strives to "discover, manufacture, and deploy advanced materials in half the time and at a fraction of the cost." Platforms respond to the increasing complexity of conducting materials research that requires the close collaboration of multidisciplinary teams who have access to cutting edge tools. To accelerate research outcomes, Platforms conduct research through iterative "closed-loop" efforts among the areas of materials synthesis, characterization, theory, and the application of theory through modeling and/or simulation. The in-house research conducted by a MIP is transformational and focuses on a targeted materials grand challenge and/or a technological outcome (e.g., understanding complexity, discovery of new phenomena and materials, etc.) that addresses a national priority.

MIPs push the frontiers in materials research by advancing the capabilities of current state-of-the-art experimental tools through the development of new techniques and the next generation of instrumentation that will lead to understanding and discovering new phenomena as well as the discovery of complex functional material systems. In addition, it is expected that open access to these cutting edge tools will strengthen collaborations among scientists and enable researchers to work in new ways, while fostering new modalities of multidisciplinary education and training. The user facility aspect of a Platform accounts for approximately 50% of the collaborative effort, where a MIP provides access to unique high-quality, state-of-the-art instrumentation and technological services through a staff of experts that are accessible to external researchers and all types of institutions. Due to this convergence of expertise, MIPs will serve as focal points that promote cross-fertilization of ideas between internal and external researchers.

The Platform, the tools and techniques developed, and the resulting new materials are themselves meant to be transformative. The US, once a global leader in materials synthesis, has fallen behind in the science of crystal growth. To rebuild technical strength in this area, the initial MIPs will focus on developing new bulk and thin film crystalline hard materials. The scientific focus of the MIP program is subject to change from competition to competition. MIPs are anticipated to be five year awards totaling $10,000,000 to $25,000,000 for the award period. MIP awards are eligible for a one-time five-year renewal, subsequent to a rigorous and favorable review by NSF. To cover the breadth of this endeavor, it is expected that proposed projects will be directed by a team of at least three Senior Personnel with complementary expertise. Equipment acquisition is expected in the first few years, but yearly budget should not exceed $7.0M.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
National Institutes of Health (NIH)

The National Institutes of Health, Department of Health and Human Services has announced the following new funding opportunity:

BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit Specific Processes in the Brain (U01)

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.